BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 168844)

  • 1. Phosphodiesterase inhibitors and cerebral vasospasm.
    Flamm ES; Kim J; Lin J; Ransohoff J
    Arch Neurol; 1975 Aug; 32(8):569-71. PubMed ID: 168844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase inhibitors and cerebral vasospasm.
    Flamm ES; Kim J; Lin J; Ransohoff J
    Trans Am Neurol Assoc; 1974; 99():137-40. PubMed ID: 4377047
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental cerebral vasospasm and cyclic adenosine monophosphate (c-AMP).
    Kim J; Flamm ES; Lin J
    Invest Radiol; 1975; 10(3):239-43. PubMed ID: 166052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate.
    Flamm ES; Ransohoff J
    Surg Neurol; 1976 Oct; 6(4):223-6. PubMed ID: 184555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental alterations in cyclic adenosine monophosphate concentrations in the cat basilar artery.
    Flamm ES; Viau A; Ransohoff J; Naftchi NE
    Neurology; 1976 Jul; 26(7):664-6. PubMed ID: 180456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminophylline and isoproterenol in the treatment of cerebral vasopasm.
    Fleischer AS; Raggio JF; Tindall GT
    Surg Neurol; 1977 Aug; 8(2):117-21. PubMed ID: 888087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous ethanol on cerebral vasospasm produced by subarachnoid blood.
    Barry KJ; Scott RM
    Stroke; 1979; 10(5):535-7. PubMed ID: 505494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline toxicity after the use of aminophylline in the treatment of cerebral vasospasm.
    Bailey RT; Young B; Rapp RP; Blouin RA
    Neurosurgery; 1981 Dec; 9(6):722-4. PubMed ID: 7322341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral vasospasm following aneurysm rupture. A protocol for therapy and prophylaxis.
    Fleischer AS; Tindall GT
    J Neurosurg; 1980 Feb; 52(2):149-52. PubMed ID: 7351553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ther reversal of experimental vasospasm by dibutyryl-3',5'-adenosine monophosphate.
    Peterson EW; Searle R; Mandy FF; Leblanc R
    J Neurosurg; 1973 Dec; 39(6):730-4. PubMed ID: 4357243
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experiment delayed cerebral arterial spasm with a beta2-adrenergic stimulator and a phosphodiesterase inhibitor.
    Norwood CW; Poole J; Moody D
    J Neurosurg; 1976 Nov; 45(5):491-7. PubMed ID: 823307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of theophylline and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO 20-1724) on protein secretion from rat parotid gland.
    Afari G; Tenenhouse A; Vachon C
    Br J Pharmacol; 1982 Nov; 77(3):405-11. PubMed ID: 6291691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A theory of the mechanism of cerebral vasospasm and its reversal, the role of calcium and cyclic AMP.
    Peterson EW; Leblanc R
    Can J Neurol Sci; 1976 Nov; 3(4):223-6. PubMed ID: 187308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.
    Varsos VG; Liszczak TM; Han DH; Kistler JP; Vielma J; Black PM; Heros RC; Zervas NT
    J Neurosurg; 1983 Jan; 58(1):11-7. PubMed ID: 6847896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of acute experimental cerebral vasospasm by calcium antagonism with verapamil.
    Leblanc R; Feindel W; Yamamoto L; Milton JG; Frojmovic MM
    Can J Neurol Sci; 1984 Feb; 11(1):42-7. PubMed ID: 6704793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prostacyclin on cerebral vasospasm. An experimental study.
    Quintana L; Konda R; Ishibashi Y; Yoshimoto T; Suzuki J
    Acta Neurochir (Wien); 1982; 62(3-4):187-93. PubMed ID: 7048862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626).
    Alksne JF; Branson PJ
    Stroke; 1979; 10(6):638-44. PubMed ID: 118551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cerebral vasospasm.
    Peterson EW; Mandy FF; Searle R; Leblanc R
    Lancet; 1973 Jun; 1(7818):1513. PubMed ID: 4123178
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
    Kather H; Scheurer A
    Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.